Remove 2011 Remove Acquisition Remove Blogging Remove Study
article thumbnail

Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More

Xconomy

Some observers’ minds instantly jumped to business —Gilead needs to pick up the acquisition pace to find its next big thing. After all, Gilead’s $11 billion purchase of Pharmasset in 2011, roundly jeered as an overpay at the time, brought it sofosbuvir. But our minds jumped to politics.

Startup 40
article thumbnail

Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More

Xconomy

[ Editor’s note: Ben Fidler and Sarah de Crescenzo coauthored this report.] It is here, and then it is gone. But by the time everyone staggers to the airport or back home to sleep in their own beds, the annual few days of the J.P.

Pricing 97
article thumbnail

Top 120 Startup Posts for 2010

SoCal CTO

My 1,000th Post on This Blog - Tim Berry's Blog - Planning Startups Stories , July 21, 2010 HTML5 video markup, compatibility and playback - Niall Kennedy's Weblog , February 8, 2010 Your Product Needs a Soul - ArcticStartup , February 12, 2010 Product Friday: Monetizing Content is a Product Problem - This is going to be BIG.

Startup 378